Matrix metalloproteinase expression patterns in luminal A type breast carcinomas

Disease Markers

Volumn 23, Issue 3, 2007, Pages 189-196

  Decock, J ^a   Hendrickx, W ^a   Drijkoningen, M ^a   Wildiers, H ^a   Neven, P ^a   Smeets, A ^a   Paridaens, R ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Breast cancer; Clinicopathological parameters; Luminal A; Matrix metalloproteinases; Menopausal status

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; RNA; STROMELYSIN 2; STROMELYSIN 3;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER INVASION; CANCER SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME REGULATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MEDICAL PARAMETERS; MENOPAUSE; NUCLEOTIDE SEQUENCE; PILOT STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 34249897181     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/281727     Document Type: Article

References (24)

1. L.A. Carey, C.M. Perou, C.A. Livasy, L.G. Dressler, D. Cowan, K. Conway, G. Karaca, M.A. Troester, C.K. Tse, S. Edmiston, S.L. Deming, J. Geradts, M.C. Cheang, T.O. Nielsen, P.G. Moorman, H.S. Earp and R.C. Millikan, Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study, JAMA 295 (2006), 2492-2502.
2. J. Decock, W. Hendrickx, H. Wildiers, M.R. Christiaens, P. Neven, M. Drijkoningen and R. Paridaens, Plasma gelatinase levels in patients with primary breast cancer in relation to axillary lymph node status, Her2/neu expression and other clinicopathological variables, Clin Exp Metastasis 22 (2005), 495-502.
3. M.J. Duffy, T.M. Maguire, A. Hill, E. McDermott and N. O'Higgins, Metalloproteinases: role in breast carcinogenesis, invasion and metastasis, Breast Cancer Res 2 (2000), 252-257.
4. S.Q. Fan, Q.Y. Wei, M.R. Li, L.Q. Zhang and Q.C. Liang, Expression and clinical significance of MMP-2, MMP-9, TIMP-1, and TIMP-2 in breast carcinoma, Ai Zheng 22 (2003), 968-973.
5. A.R. Folgueras, A.M. Pendas, L.M. Sanchez and C. Lopez-Otin, Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies, Int J Dev Biol 48 (2004), 411-424.
6. D. Giunciuglio, M. Culty, G. Fassina, L. Masiello, A. Melchiori, G. Paglialunga, G. Arand, F. Ciardiello, F. Basolo and E.W. Thompson, Invasive phenotype of MCF10A cells over-expressing c-Ha-ras and c-erbB-2 oncogenes, Int J Cancer 63 (1995), 815-822.
7. M.M. Gueders, J.M. Foidart, A. Noel and D.D. Cataldo, Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases, Eur J Pharmacol 533 (2006), 133-144.
8. S.K. Katiyar, Matrix metalloproteinases in cancer metastasis: molecular targets for prostate cancer prevention by green tea polyphenols and grape seed proanthocyanidins, Endocr Metab Immune Disord Drug Targets 6 (2006), 17-24.
9. G. La Rocca, I. Pucci-Minafra, A. Marrazzo, P. Taormina and S. Minafra, Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera, Br J Cancer 90 (2004), 1414-1421.
10. R. la-aho and V.M. Kahari, Collagenases in cancer, Biochimie 87 (2005), 273-286.
11. A. Lebeau, C. Muller-Aufdemkamp, C. Allmacher, U. Sauer, A. Nerlich, R. Lichtinghagen and U. Lohrs, Cellular protein and mRNA expression patterns of matrix metalloproteinases-2, -3 and -9 in human breast cancer: correlation with tumour growth, J Mol Histol 35 (2004), 443-455.
12. A.S. Mellick, D. Blackmore, S.R.Weinstein and L.R. Griffiths, An assessment of MMP and TIMP gene expression in cell lines and stroma - tumour differences in microdissected breast cancer biopsies, Tumour Biol 24 (2003), 258-270.
13. M.M. Mueller and N.E. Fusenig, Friends or foes - bipolar effects of the tumour stroma in cancer, Nat Rev Cancer 4 (2004), 839-849.
14. M.M. Pacheco, M. Mourao, E.B. Mantovani, I.N. Nishimoto and M.M. Brentani, Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinico-pathological correlations, Clin Exp Metastasis 16 (1998), 577-585.
15. J.M. Pellikainen, K.M. Ropponen, V.V. Kataja, J.K. Kellokoski, M.J. Eskelinen and V.M.Kosma, Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis, Clin Cancer Res 10 (2004), 7621-7628.
16. A. Roetger, A. Merschjann, T. Dittmar, C. Jackisch, A. Barnekow and B. Brandt, Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model, Am J Pathol 153 (1998), 1797-1806.
17. T. Sorlie, C.M. Perou, R. Tibshirani, T. Aas, S. Geisler, H. Johnsen, T. Hastie, M.B. Eisen, R.M. van de, S.S. Jeffrey, T. Thorsen, H. Quist, J.C. Matese, P.O. Brown, D. Botstein, L.P. Eystein and A.L. Borresen-Dale, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Natl Acad Sci USA 98 (2001), 10869-10874.
18. T. Sorlie, R. Tibshirani, J. Parker, T. Hastie, J.S. Marron, A. Nobel, S. Deng, H. Johnsen, R. Pesich, S. Geisler, J. Demeter, C.M. Perou, P.E. Lonning, P.O. Brown, A.L. Borresen-Dale and D. Botstein, Repeated observation of breast tumor subtypes in independent gene expression data sets, Proc Natl Acad Sci USA 100 (2003), 8418-8423.
19. M. Tan, J. Yao and D. Yu, Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities, Cancer Res 57 (1997), 1199-1205.
20. B. Tetu, J. Brisson, H. Lapointe and P. Bernard, Prognostic significance of stromelysin 3, gelatinase A, and urokinase expression in breast cancer, Hum Pathol 29 (1998), 979-985.
21. T. Turpeenniemi-Hujanen, Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers, Biochimie 87 (2005), 287-297.
22. C.H. Xiao, Y.M. Feng, X.Q. Li and X.S. Hao, Clinical significance and relationship of expression of matrix metalloproteinase-2 mRNA with breast cancer metastasis, Zhonghua Wai Ke Za Zhi 43 (2005), 599-604.
23. F.J. Xu, S. Stack, C. Boyer, K. O'Briant, R. Whitaker, G.B. Mills, Y.H. Yu and R.C. Bast, Jr., Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(cerbB2): increased invasiveness may contribute to poor prognosis, Clin Cancer Res 3 (1997), 1629-1634.
24. S. Zucker and J. Vacirca, Role of matrix metalloproteinases (MMPs) in colorectal cancer, Cancer Metastasis Rev 23 (2004), 101-117.